Prospective Study of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma on Waitlist for Liver Transplant.
Tiffany Cho-Lam WongVictor Ho-Fun LeeAda Lai-Yau LawHerbert H PangKa-On LamVince LauTracy Yushi CuiAdrianna Sze-Yin FongSarah Wai-Man LeeEdwin Chun-Yin WongJeff Wing-Chiu DaiAlbert Chi-Yan ChanTan-To CheungJames Yan-Yue FungRebecca Mei-Wan YeungMai-Yee LukTo-Wai LeungChung-Mau LoPublished in: Hepatology (Baltimore, Md.) (2021)
SBRT was safe, with a significantly higher tumor control rate, reduced the risk of waitlist dropout, and should be used as an alternative to conventional bridging therapies.